Elan climbs on upgrade amid drug-stock gains
Elan climbs on upgrade amid drug-stock gains
BOSTON (MarketWatch) — Drugs stocks climbed into positive territory early Tuesday as shares of Elan Corp. gained after analysts at Canaccord upgraded the stock to hold from sell.
Add A Comment